{"id":"https://openalex.org/W3025755609","doi":null,"title":"[Present and Future of an iPS Cell Stock for Regenerative Medicine].","display_name":"[Present and Future of an iPS Cell Stock for Regenerative Medicine].","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-01","ids":{"openalex":"https://openalex.org/W3025755609","mag":"3025755609","pmid":"https://pubmed.ncbi.nlm.nih.gov/30762982"},"language":"ja","primary_location":{"id":"pmid:30762982","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30762982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rinsho byori. The Japanese journal of clinical pathology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W3025755609"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072936833","display_name":"Tadaaki Hanatani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tadaaki Hanatani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047238598","display_name":"Naoko Takasu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Naoko Takasu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"65","issue":"2","first_page":"160","last_page":"166"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/induced-pluripotent-stem-cells","display_name":"induced pluripotent stem cells","score":0.9409999847412109},{"id":"https://openalex.org/keywords/hla-matching","display_name":"HLA matching","score":0.8339999914169312},{"id":"https://openalex.org/keywords/graft-rejection","display_name":"graft rejection","score":0.6579999923706055},{"id":"https://openalex.org/keywords/tumorigenicity","display_name":"tumorigenicity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/genomic-abnormalities","display_name":"genomic abnormalities","score":0.9449999928474426},{"id":"https://openalex.org/keywords/cell-therapy-safety","display_name":"cell therapy safety","score":0.8870000243186951},{"id":"https://openalex.org/keywords/regenerative-medicine","display_name":"regenerative medicine","score":0.828000009059906},{"id":"https://openalex.org/keywords/graft-survival","display_name":"graft survival","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.8434255123138428},{"id":"https://openalex.org/C3017619653","wikidata":"https://www.wikidata.org/wiki/Q187860","display_name":"Stock options","level":2,"score":0.6252624988555908},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6127302050590515},{"id":"https://openalex.org/C204036174","wikidata":"https://www.wikidata.org/wiki/Q909380","display_name":"Stock (firearms)","level":2,"score":0.5335557460784912},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4928727149963379},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.405561625957489},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3127226233482361},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3017256259918213},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2365131378173828},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.18203824758529663},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.16875755786895752},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.16792798042297363},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16761839389801025},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.13767290115356445},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0934763252735138},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0902499258518219},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044968","descriptor_name":"Regenerative Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057026","descriptor_name":"Induced Pluripotent Stem Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064987","descriptor_name":"Cell- and Tissue-Based Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:30762982","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30762982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rinsho byori. The Japanese journal of clinical pathology","raw_type":"Journal Article"},{"id":"mag:3025755609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30762982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4309335008","https://openalex.org/W4318986936","https://openalex.org/W2970240057","https://openalex.org/W3097861451","https://openalex.org/W4402542826","https://openalex.org/W4415637686","https://openalex.org/W4389670658","https://openalex.org/W177199058","https://openalex.org/W4389914508","https://openalex.org/W4407094389"],"abstract_inverted_index":{"A":[0,80],"haplobank":[1],"of":[2,39,42,48,60,63,71,106,150,158,176,190,216,228],"induced":[3],"pluripotent":[4],"stem":[5],"cell":[6,166,217],"(iPSC)":[7],"lines":[8,120],"derived":[9],"from":[10],"healthy":[11],"donors":[12],"with":[13,57,76,93,103,155,171],"homozygous":[14,104],"human":[15],"leukocyte":[16],"antigen(HLA),":[17],"which":[18,231],"is":[19,33,180,220,232],"called":[20],"\"an":[21],"iPSC":[22,31,78,101,136,151,207],"stock\",":[23],"has":[24],"been":[25],"under":[26],"construction":[27],"in":[28,55,115,140,200],"Japan.":[29],"The":[30],"stock":[32,137],"expected":[34],"to":[35,91,128,146,184,186,223,234],"enable":[36],"HLA":[37,105,229],"matching":[38],"a":[40,99,113],"majority":[41],"recipients":[43],"and":[44,69,83,174,214,238],"reduce":[45,239],"the":[46,58,64,72,77,107,116,130,135,148,156,159,177,188,212,225],"risk":[47],"trans-":[49],"plant":[50],"rejection.":[51],"Full-scale":[52],"operations":[53],"began":[54],"FY2013,":[56],"aim":[59],"covering":[61],"30-50%":[62],"Japanese":[65],"population":[66,73],"by":[67,74],"FY2017":[68],"most":[70],"FY2022":[75],"stock.":[79,152],"novel":[81],"feeder-free":[82],"xeno-free":[84],"culture":[85],"system":[86],"for":[87],"iPSCs":[88],"was":[89,110],"developed":[90],"comply":[92],"regulatory":[94],"safety":[95,162],"standards.":[96],"In":[97,153],"2015,":[98],"clinical-grade":[100,119],"line":[102],"highest-frequency":[108],"haplotype":[109],"released":[111],"as":[112],"first":[114,131],"world.":[117],"Other":[118],"are":[121,168],"being":[122,169],"generated":[123],"successively.":[124],"If":[125],"all":[126],"goes":[127],"plan,":[129],"clinical":[132,226],"research":[133],"using":[134],"will":[138],"start":[139],"2017.":[141],"However,":[142],"many":[143],"challenges":[144],"remain":[145],"ensuring":[147],"future":[149],"accordance":[154],"progress":[157],"latest":[160],"research,":[161],"issues":[163],"regarding":[164],"iPSC-based":[165],"therapy":[167],"monitored":[170],"much":[172],"interest,":[173],"one":[175],"major":[178],"concerns":[179],"tumorigenicity.":[181],"We":[182],"have":[183],"continue":[185],"discuss":[187],"extent":[189],"genomic":[191],"abnormalities":[192],"that":[193],"would":[194,196],"or":[195],"not":[197,201],"be":[198],"acceptable":[199],"only":[202],"iPSC-derived":[203],"products":[204],"but":[205],"also":[206,221],"stock,":[208],"taking":[209],"into":[210],"account":[211],"risks":[213],"benefits":[215],"therapy.":[218],"It":[219],"necessary":[222],"demonstrate":[224],"efficacy":[227],"matching,":[230],"indicated":[233],"promote":[235],"graft":[236],"survival":[237],"immunosuppressive":[240],"drug":[241],"use.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3025755609","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-05-21T00:00:00"}
